Introduction
INVASIVE CANCER, PRECANCEROUS LESIONS, CERVICAL CANCER
The World Health Organization (WHO) estimates that implementation of cost-effective and evidence-based interventions, including human papillomavirus (HPV) vaccination of girls, screening and treatment of precancerous lesions, and improving access to diagnosis and treatment of invasive cancers will reduce the median cervical cancer (CC) incidence rate by 97% by 2120– averting more than 74 million new cases of cervical cancer between 2020 and 2120 [Several interventions have been implemented to increase early detection of CC among women globally, including health education interventions [
Conceptual framework for promotion of cervical cancer (CC) prevention advocacy among screened women to affect CC screening among social network membersWe conducted a pilot randomized controlled trial of GC-CCP and found that the intervention led to increased engagement in CC prevention advocacy, and uptake of CC screening in over half of the previously unscreened women in the social networks of the intervention group, compared to less than one-fifth of their counterparts in the control group (Wagner et al., 